All Pharma News
price-trendAsk Us
Gesynta Pharma receives orphan drug designation by FDA for systemic sclerosis

Gesynta Pharma receives orphan drug designation by FDA for systemic sclerosis
PHARMAFILE
27 Apr 2022
Share Share
Gesynta Pharma receives orphan drug designation by FDA for systemic sclerosis

Gesynta Pharma receives orphan drug designation by FDA for systemic sclerosis
PHARMAFILE
26 Apr 2022
Share Share
Gesynta Pharma announces development program for its drug candidate GS-248

Gesynta Pharma announces development program for its drug candidate GS-248
CISION
14 Jun 2021
Share Share
Gesynta Pharma initiates Phase II study

Gesynta Pharma initiates Phase II study
PRESS RELEASE
28 Jan 2021
Share Share